---
$id: https://graph.org.ai/products/commodity/51413903
$type: Product
source: UNSPSC
code: "51413903"
title: "Cinepaxadil"
class: "51413900"
classTitle: "Vasodilators, synthesized"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinepaxadil

**UNSPSC Code**: 51413903
**Class**: [Vasodilators, synthesized](Vasodilators, synthesized.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vasodilating agent with the molecular formula C29H36N2O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E052L8N506, chemically known as alpha-(((8-acetyl-1,4-benzodioxan-5-yl)oxy)methyl)-4-(3,4,5-trimethoxycinnamoyl)-1-piperazineethanol but generally known as cinepaxadil, which bears US NIH Compound Identifier 6436099. European Medicines Agency schedules Cinepaxadil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06290MIG. The term CINEPAXADIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). CINEPAXADIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinepaxadil under HS 29349990 and SITC 51579. As of Q4 2014, CINEPAXADIL remains the US FDA Preferred Term for this commodity. Cinepaxadil bears US NLM identifiers UMLS ID C2983977 and NCI Concept Code C90999. SMILES: OC(CN1CCN(CC1)C(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)COc1c2OCCOc2c(cc1)C(=O)C.

